Grantable
Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC) Grant · THE PFIZER FOUNDATION INC
up to $100,000
Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC) Grant Status: ACTIVE Funder: Pfizer, Inc. Amount: Up to US $100,000 Last Updated: December 08, 2025 Summary Pfizer is launching a grant initiative to enhance care for patients wi…
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.